Amy (Proctor) Madl, Ph.D., prosecutes and provides strategic counseling on U.S. and foreign patent portfolios in the chemical, pharmaceutical, and biotechnology fields; provides validity and patentability opinions; and prepares freedom-to-operate analyses. She also assists in due diligence matters, pre-litigation investigations, and post-grant proceedings before the Patent Trial and Appeal Board (PTAB) of the U.S. Patent and Trademark Office (USPTO).
With a doctorate in chemical engineering from Stanford University, Amy applies her broad technical experience in materials science, rheology, and polymer-based protein engineering to intellectual property matters. She has developed global prosecution strategies and prosecuted patent applications involving diverse technologies, including polymer-based technologies, industrial coatings, catalysts, small molecule pharmaceuticals, and synthetic biology tools. She conducts freedom-to-operate assessments and landscape evaluations and provides patentability, validity, and infringement opinions. Amy assists in Orange Book listings of patents covering FDA-approved drugs, pre-litigation analyses, due diligence investigations, and post-grant proceedings, including inter partes reviews (IPRs) before the PTAB.
Amy practiced at Finnegan as a technical specialist and as a student associate while attending Stanford Law School, where she received several prizes for outstanding performance and served as executive editor of the Stanford Law Review. Amy’s graduate thesis focused on developing soft materials and rheological techniques to model and restore ocular health. She has coauthored thirteen peer-reviewed scientific publications and three law review articles.
Articles in the National Law Review database by Amy C. Madl, Ph.D.